NSE filing, NSE: GHCL. Summary written from the filing by ALFA Finder's alert engine.
GHCL Ltd: key numbers
- Share price
- ₹386.50
- Market cap
- ₹3,561 Cr
- Revenue (annual)
- ₹3,064 Cr
- Net profit (annual)
- ₹478.8 Cr
- P/E (TTM)
- 6.8×Sector 34.1×
- Promoter holding
- 19.83%+0.00% QoQ
- FII holding
- 21.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GHCL Ltd
All →GHCL Board Meeting Date
GHCL scheduled its 219th Board Meeting for October 31, 2026, to consider Q1 FY27 unaudited results. Trading window remains closed until November 2, 2026.
GHCL Production Started
GHCL commenced commercial production of Bromine on October 12, 2026, with annual capacity of 2800 MT. The product targets both domestic and international markets.
- Bromine annual production capacity
- 2800 MT
GHCL Product Launch
GHCL launches Liquid Bromine (Br2) for domestic and international markets. Annual capacity of 2,800 MT strengthens its commodity chemicals portfolio.
- Bromine production capacity
- 2800 MT
GHCL Other Announcement
GHCL Ltd has filed its quarterly shareholding pattern disclosure as required under SEBI regulations. The statement provides the distribution of shares across various investor categories.
GHCL Other Announcement
Designated person Manoj Kumar Ishwar purchased 600 equity shares of GHCL Ltd worth Rs. 2.42 Lakhs via a market transaction.
- Value
- ₹0.02 Cr
GHCL Bags New Order from Commissioner of Geology and Mining, Government of Gujarat
GHCL Limited has been declared the "Preferred Bidder" for a limestone mine in Gujarat's Kadaya Block, securing rights for a 6.8797-hectare area.
- From
- Commissioner of Geology and Mining, Government of Gujarat
- limestone mineral reserve
- 567337.0 Metric Tonne
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date